BFS
OCGN icon

Bradley Foster & Sargent’s Ocugen OCGN Stock Holding History

Bradley Foster & Sargent’s Portfolio OCGN Stock Details OCGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-1,203
Closed -$180K – 378
2018
Q2 		$180K Hold
1,203
– – 0.01% 359
2018
Q1 		$199K Buy
+1,203
New +$192K 0.01% 344

Other funds holding OCGN

TS
Third Security Radford, Virginia $241M AUM 45.43% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
A
Abingworth London, United Kingdom $307M AUM 93.47% 1-Year Est. Return
ACM
Archon Capital Management Seattle, Washington $177M AUM 108.05% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return

Bradley Foster & Sargent's OCGN Position: Q3 2018 in Review

Bradley Foster & Sargent sold out of Ocugen (OCGN) in Q3 2018, closing a stake of 1,203 shares — an estimated $180K sold.

Bradley Foster & Sargent first reported a position in OCGN in Q1 2018 and held it in 2 quarters. The position peaked at $199K in Q1 2018. 30 funds tracked by Wall St. Rank hold OCGN as of Q3 2018.

  • Bradley Foster & Sargent reported no remaining Ocugen position as of Q3 2018 after selling out during the quarter.
  • Bradley Foster & Sargent sold 1,203 Ocugen shares in Q3 2018, an estimated $180K.
  • Bradley Foster & Sargent first reported a position in Ocugen in Q1 2018 and held it in 2 quarters.
  • Bradley Foster & Sargent's Ocugen position peaked at $199K in Q1 2018.
  • 30 funds tracked by Wall St. Rank held Ocugen as of Q3 2018.

Based on Bradley Foster & Sargent's 13F filing for Q3 2018, filed 31 Oct 2018.